Logo image of MSB

MESABI TRUST (MSB) Stock Fundamental Analysis

NYSE:MSB - New York Stock Exchange, Inc. - US5906721015 - Currency: USD

23.31  -0.69 (-2.88%)

After market: 23.31 0 (0%)

Fundamental Rating

7

Overall MSB gets a fundamental rating of 7 out of 10. We evaluated MSB against 154 industry peers in the Metals & Mining industry. MSB has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. MSB has a correct valuation and a medium growth rate. These ratings would make MSB suitable for quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year MSB was profitable.
MSB had a positive operating cash flow in the past year.
Each year in the past 5 years MSB has been profitable.
MSB had a positive operating cash flow in each of the past 5 years.
MSB Yearly Net Income VS EBIT VS OCF VS FCFMSB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

1.2 Ratios

With an excellent Return On Assets value of 91.69%, MSB belongs to the best of the industry, outperforming 99.35% of the companies in the same industry.
MSB has a Return On Equity of 399.85%. This is amongst the best in the industry. MSB outperforms 100.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 315.88%, MSB belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MSB is significantly above the industry average of 11.16%.
The 3 year average ROIC (152.08%) for MSB is below the current ROIC(315.88%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 91.69%
ROE 399.85%
ROIC 315.88%
ROA(3y)66.81%
ROA(5y)86.02%
ROE(3y)178.92%
ROE(5y)180.43%
ROIC(3y)152.08%
ROIC(5y)151.27%
MSB Yearly ROA, ROE, ROICMSB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500 1K 1.5K

1.3 Margins

The Profit Margin of MSB (94.60%) is better than 100.00% of its industry peers.
MSB's Profit Margin has been stable in the last couple of years.
The Operating Margin of MSB (94.60%) is better than 100.00% of its industry peers.
MSB's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 94.6%
PM (TTM) 94.6%
GM N/A
OM growth 3Y-0.05%
OM growth 5Y0.34%
PM growth 3Y-0.57%
PM growth 5Y0.13%
GM growth 3YN/A
GM growth 5YN/A
MSB Yearly Profit, Operating, Gross MarginsMSB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

8

2. Health

2.1 Basic Checks

The number of shares outstanding for MSB remains at a similar level compared to 1 year ago.
Compared to 5 years ago, MSB has about the same amount of shares outstanding.
There is no outstanding debt for MSB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MSB Yearly Shares OutstandingMSB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
MSB Yearly Total Debt VS Total AssetsMSB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 6.93 indicates that MSB is not in any danger for bankruptcy at the moment.
MSB has a Altman-Z score of 6.93. This is in the better half of the industry: MSB outperforms 79.35% of its industry peers.
There is no outstanding debt for MSB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.93
ROIC/WACCN/A
WACCN/A
MSB Yearly LT Debt VS Equity VS FCFMSB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.3 Liquidity

MSB has a Current Ratio of 1.30. This is a normal value and indicates that MSB is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of MSB (1.30) is worse than 76.77% of its industry peers.
A Quick Ratio of 1.30 indicates that MSB should not have too much problems paying its short term obligations.
MSB has a Quick ratio of 1.30. This is comparable to the rest of the industry: MSB outperforms 45.81% of its industry peers.
The current and quick ratio evaluation for MSB is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 1.3
MSB Yearly Current Assets VS Current LiabilitesMSB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

MSB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 390.51%, which is quite impressive.
MSB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 25.43% yearly.
MSB shows a strong growth in Revenue. In the last year, the Revenue has grown by 331.27%.
MSB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.25% yearly.
EPS 1Y (TTM)390.51%
EPS 3Y10.7%
EPS 5Y25.43%
EPS Q2Q%28.44%
Revenue 1Y (TTM)331.27%
Revenue growth 3Y11.33%
Revenue growth 5Y25.25%
Sales Q2Q%10.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MSB Yearly Revenue VS EstimatesMSB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 3.28 indicates a rather cheap valuation of MSB.
Based on the Price/Earnings ratio, MSB is valued cheaper than 100.00% of the companies in the same industry.
MSB is valuated cheaply when we compare the Price/Earnings ratio to 26.35, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.28
Fwd PE N/A
MSB Price Earnings VS Forward Price EarningsMSB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, MSB is valued cheaply inside the industry as 98.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.26
EV/EBITDA N/A
MSB Per share dataMSB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The excellent profitability rating of MSB may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.13
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 20.38%, MSB is a good candidate for dividend investing.
MSB's Dividend Yield is rather good when compared to the industry average which is at 2.98. MSB pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, MSB pays a better dividend.
Industry RankSector Rank
Dividend Yield 20.38%

5.2 History

The dividend of MSB decreases each year by -16.67%.
MSB has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of MSB decreased in the last 3 years.
Dividend Growth(5Y)-16.67%
Div Incr Years2
Div Non Decr Years2
MSB Yearly Dividends per shareMSB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

MSB pays out 18.99% of its income as dividend. This is a sustainable payout ratio.
DP18.99%
EPS Next 2YN/A
EPS Next 3YN/A
MSB Yearly Income VS Free CF VS DividendMSB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
MSB Dividend Payout.MSB Dividend Payout, showing the Payout Ratio.MSB Dividend Payout.PayoutRetained Earnings

MESABI TRUST

NYSE:MSB (6/20/2025, 8:04:00 PM)

After market: 23.31 0 (0%)

23.31

-0.69 (-2.88%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)06-11 2025-06-11
Earnings (Next)09-03 2025-09-03
Inst Owners43.99%
Inst Owner Change-5.15%
Ins Owners0.08%
Ins Owner Change0%
Market Cap305.83M
Analysts0
Price TargetN/A
Short Float %3.33%
Short Ratio10.45
Dividend
Industry RankSector Rank
Dividend Yield 20.38%
Yearly Dividend1.35
Dividend Growth(5Y)-16.67%
DP18.99%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-30 2025-04-30 (0.56)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.28
Fwd PE N/A
P/S 3.1
P/FCF 3.26
P/OCF 3.26
P/B 13.11
P/tB 13.11
EV/EBITDA N/A
EPS(TTM)7.11
EY30.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)7.16
FCFY30.72%
OCF(TTM)7.16
OCFY30.72%
SpS7.51
BVpS1.78
TBVpS1.78
PEG (NY)N/A
PEG (5Y)0.13
Profitability
Industry RankSector Rank
ROA 91.69%
ROE 399.85%
ROCE 399.85%
ROIC 315.88%
ROICexc N/A
ROICexgc N/A
OM 94.6%
PM (TTM) 94.6%
GM N/A
FCFM 95.27%
ROA(3y)66.81%
ROA(5y)86.02%
ROE(3y)178.92%
ROE(5y)180.43%
ROIC(3y)152.08%
ROIC(5y)151.27%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)192.5%
ROCE(5y)191.48%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.05%
OM growth 5Y0.34%
PM growth 3Y-0.57%
PM growth 5Y0.13%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 100.71%
Current Ratio 1.3
Quick Ratio 1.3
Altman-Z 6.93
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)146.22%
Profit Quality(5y)123.79%
High Growth Momentum
Growth
EPS 1Y (TTM)390.51%
EPS 3Y10.7%
EPS 5Y25.43%
EPS Q2Q%28.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)331.27%
Revenue growth 3Y11.33%
Revenue growth 5Y25.25%
Sales Q2Q%10.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y391.36%
EBIT growth 3Y11.27%
EBIT growth 5Y25.67%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y543.13%
FCF growth 3Y14.34%
FCF growth 5Y22.12%
OCF growth 1Y543.13%
OCF growth 3Y14.34%
OCF growth 5Y22.12%